Freed, a San Francisco, CA-based health tech company focused on freeing clinicians from administrative burdens, has raised $30 million in Series A funding. 

Investors 

The round was led by Sequoia Capital, with participation from Scale Venture Partners, Daniel Gross, Gokul Rajaram, and Ted Zagat. 

Sequoia Capital, headquartered in Menlo Park, California, is a venture capital firm specializing in seed-stage, early-stage, and growth-stage investments across technology sectors. It helps founders build legendary companies from inception to IPO and beyond. 

Freed Use of Funds 

The funding will fuel Freed’s rapid expansion beyond AI note writing, building a next-generation AI clinician assistant.  

About Freed 

Freed provides an AI-powered clinician assistant designed to eliminate the burdens of medical documentation. The company uses AI to automate note writing, streamline EHR workflows, and reduce burnout, freeing clinicians from late-night charting and administrative overload. The company aims to help clinicians reclaim their time, reduce stress, and ultimately improve healthcare outcomes. Launched in 2023, Freed’s now serves over 17,000 paying users.  

Funding Details 

Company: Freed, Inc. 

Raised: $30.0M 

Round: Series A 

Funding Date: March 2025 

Lead Investor: Sequoia Capital 

Additional Investors: Scale Venture Partners, Daniel Gross, Gokul Rajaram, Ted Zagat 

Company Website: https://www.getfreed.ai/  

Software Category: Clinical Workflow Management 

Source: https://www.businesswire.com/news/home/20250305397400/en/